Baxter International (BAX) is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this Zacks Rank #3 (Hold) company have gained 10.8% year to date compared with the industry's 5.3% growth. The S&P 500 Index has increased 9.4% in the same time frame.BAX, with a market capitalization of $21.46 billion, is a global medical technology company providing items such as kidney-dialysis equipment, ...